Medlinker is a Chinese medical AI platform focused on chronic disease management, pairing specialist doctors with AI tools for continuous patient care.
Medlinker built its platform around chronic disease, where continuous management matters more than episodic visits. It connects patients with specialist physicians who use the platform’s AI tools to monitor conditions, adjust treatment plans, and intervene when data suggests deterioration. The system aggregates patient-reported data, medication adherence, and examination results into physician dashboards, applying models that flag at-risk patients for outreach. Its disease-management programs concentrate in areas such as diabetes, hepatitis, and respiratory disease, and its clinical AI research has been published in international journals. For patients, the experience is ongoing access to a care team rather than a one-off consultation; for physicians, it is a panel-management capability that makes continuous care economically feasible. The platform’s approach reflects a shift in Chinese healthcare toward managed chronic care, supported by policy and by the reality that chronic conditions dominate the country’s growing disease burden. Program outcomes are tracked against clinical indicators rather than engagement alone, giving healthcare partners evidence that continuous digital management changes disease trajectories rather than merely keeping patients logging in regularly.
Medlinker’s disease-management programs are offered through healthcare partners and employer arrangements, with pricing structured around program enrollment and clinical services delivered.
Patients managing chronic conditions in China who want ongoing specialist involvement, and healthcare organizations building chronic care programs that scale beyond clinic visits. It fits disease areas where outcomes depend heavily on daily self-management and timely clinical adjustment between appointments.